Form 4: U.S. Physical Therapy Director Edward Kuntz Sells 2,500 Shares
SEC Form 4 Filing
Director Edward Kuntz of U.S. Physical Therapy Inc. reports selling 2,500 shares of common stock at an average price of $107.57 on May 15, 2024.
Summary
- On May 15, 2024, Edward Kuntz, a director of U.S. Physical Therapy Inc., sold 2,500 shares of the company's common stock.
- The sale was executed at a weighted average price of $107.57 per share.
- The prices for individual transactions ranged from $107.15 to $108.09.
- Following the transaction, Kuntz directly owns 3,280 shares of U.S. Physical Therapy Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of a stock sale by a director. It doesn't inherently indicate positive or negative sentiment about the company's future.
Industry Context
This transaction is a routine disclosure of insider trading activity. It's important to monitor such filings to gauge management's sentiment and confidence in the company's prospects. However, a single sale doesn't necessarily indicate a negative outlook.
Stakeholder Impact
- The sale of shares by a director could potentially cause minor short-term fluctuations in the stock price, but the overall impact on stakeholders is likely to be minimal.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date of transaction: Edward Kuntz sold 2,500 shares of USPH common stock. |
| 05/16/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.